1 hr ago | Newswise
New Markers of Prognosis for Cancer Therapies Highlighted
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs.
9 hrs ago | The Edmond Sun, Edmond, OK
Integris Cancer Institute celebrates grand opening
Integrated, comprehensive and advanced cancer treatment became available in central Oklahoma with the recent opening of the Integris Cancer Institute of Oklahoma on a campus shared with the ProCure Proton Therapy Center.
ASCO Releases Updated Treatment Guidelines For Patients With Stage 4 Non-Small Cell Lung Cancer
New recommendations on the use of chemotherapy to treat patients with stage 4 non-small cell lung cancer were issued today by the American Society of Clinical Oncology .
CDC survey warns us to step up fight for health
Anti-smoking advocates may have had good reason to celebrate in recent years. A string of victories - cigarette tax increases, laws banning indoor smoking and the government decision to have the Food and Drug Administration regulate tobacco - seemed to be persuading smokers to quit for good.
Goldminers sue for lung disease payout
Eighteen former workers who suffer from silicosis or silico-tuberculosis are bringing a test case against the mining giant Anglo American South Africa , a subsidiary of the UK-based Anglo American Corporation.
Researchers identify role of gene in tumor development, growth and progression
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.
Erbitux Recognized By ASCO As A 2009 Major Cancer Advance As First...
Main Category: Cancer / Oncology Also Included In: Ear, Nose and Throat Article Date: 18 Nov 2009 The American Society of Clinical Oncology has once again recognized Erbitux as one of the major clinical cancer advances of 2009.
Morphine May Help Tumors Spread in Cancer Patients
Two new studies add to growing evidence that morphine and other opiate-based painkillers may promote the growth and spread of cancer cells.
Dying man in plea for the return of village gates
THE elderly owner of Richhill Castle who is dying of lung cancer has issued a final appeal to the Government to return his gates from the Queen's residence before his life ends.
Lung cancer experts hold roundtable on new staging guide
What: The International Association for the Study of Lung Cancer will hold an expert roundtable and Web cast announcing the recent publication and impact of the IASLC's Staging Manual in Thoracic Oncology containing the recently released 7th Edition of TNM in Lung and Pleural Tumours.
Why you need to stop smoking now, especially if you're going under soon. Content courtesy of the American Society of Anesthesiologists November 19, 2009 If you smoke, anesthesiologists recommend that you stop smoking before surgery and stay off cigarettes until at least one week after surgery.
The American Cancer Society marks the 34th Great American Smokeout today, November 19, by encouraging smokers to make a plan to quit.
Folic Acid Supplementation May Increase Cancer Risk
In a study published in the November 18th issue of the Journal of the American Medical Association, heart patients in Norway had a 21% increased risk of cancer when they took large doses of folic acid and vitamin B12 over patients who did not supplement the vitamins.
Common pain relief medication may encourage cancer growth
Two new studies advance that argument and demonstrate how shielding lung cancer cells from opiates reduces cell proliferation, invasion and migration in both cell-culture and mouse models.
Pain drug morphine may accelerate cancer growth
Evidence is mounting that morphine, commonly used to manage pain, may accelerate cancer growth, but a newly-approved drug that blocks its side effects could also keep tumors from spreading, U.S. researchers said on Wednesday.
Healthbeat - Lung Cancer Surgery
Lung cancer is the leading cause of cancer mortality,with more than 160,000 deaths each year.
Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented
Synta Pharmaceuticals Corp. , a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of ...
Cancer study seeks smokers, ex-smokers
Chicago researchers are seeking current and former smokers for a study on early detection of lung cancer.
Cancer patients and doctors report drug side effects differently
In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue.
Poniard rebounds on picoplatin colon cancer data
A day after Poniard Pharmaceuticals Inc. said its drug candidate picoplatin failed to improve survival for patients with lung cancer, the company reported positive data on the drug as a treatment for colorectal cancer.
Also on Topix